Skip to content
value.today

OtoNexus Medical Technologies, Inc.

Total raised
$29 M
3 rounds on record
Latest round
$2 M
Dec 2021
First round on record
Dec 2016
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of OtoNexus Medical Technologies, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2021$2 MNo. 3Under $2 million

OtoNexus Medical Technologies, Inc.: Raise no. 3, Dec 2021

Investors in this round

21 investors had bought by the notice of Jan 14, 2022: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $5 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Caitlin Cameron · Executive Officer, Director
  • George A. Gates · Executive Officer, Director
  • Harris A. Brody · Director
  • Marion R. Foote · Director
  • Mark A. Moehring · Director
  • Rhonda F. Rhyne · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Caitlin Cameron, President and Chief Executive Officer. Newest notice filed Jan 14, 2022. Read the notice at the SEC.

optionsSEC
Dec 2018$20 MNo. 2$10 to $50 million

OtoNexus Medical Technologies, Inc.: Raise no. 2, Dec 2018

Investors in this round

190 investors had bought by the notice of Jun 4, 2021: 190 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $28 M offered; $9 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Caitlin Cameron · Executive Officer, Director
  • George A. Gates · Executive Officer, Director
  • Harris A. Brody · Director
  • Marion R. Foote · Director
  • Mark A. Moehring · Director
  • Rhonda F. Rhyne · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Caitlin Cameron, President and Chief Executive Officer. Newest notice filed Jun 4, 2021 (2 amendments). Read the notice at the SEC.

equitySEC
Dec 2016$8 MNo. 1$2 to $10 million

OtoNexus Medical Technologies, Inc.: Raise no. 1, Dec 2016

Investors in this round

80 investors had bought by the notice of Jan 12, 2017: 80 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $9 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Caitlin Cameron · Executive Officer, Director
  • George A. Gates · Executive Officer, Director
  • Harris A. Brody · Director
  • Marion R. Foote · Director
  • Mark A. Moehring · Director
  • Rhonda F. Rhyne · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Caitlin Cameron, President and Chief Executive Officer. Newest notice filed Jan 12, 2017. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • OtoNexus Medical Technologies, Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2022).

    SEC Form D · Jan 2022

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jan 2022

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of OtoNexus Medical Technologies, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by OtoNexus Medical Technologies, Inc.
NameRoleNamed in
Caitlin CameronExecutive officerJan 2022
George A. GatesExecutive officerJan 2022
Caitlin CameronDirectorJan 2022
George A. GatesDirectorJan 2022
Harris A. BrodyDirectorJan 2022
Marion R. FooteDirectorJan 2022
Mark A. MoehringDirectorJan 2022
Rhonda F. RhyneDirectorJan 2022